Kimon Stamatelopoulos
16PUBLICATIONS
78CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Apr 09, 2026
GLP-1 receptor agonists and atherosclerosis: a metabolic treatment for a cardiometabolic disease.Georgios Georgiopoulos, Simon Kraler, Kimon Stamatelopoulos
|Jan 08, 2026
Amyloid-beta (1-40) peptide is associated with systemic metabolic health.Kateryna Sopova, Dimitrios Delialis, Evmorfia Aivalioti
|Dec 07, 2025
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.Jahanzaib Khwaja, Amy A Kirkwood, Paolo Milani
|Nov 03, 2025
Improving cardiovascular risk stratification through the derivation and validation of an elevated triglyceride-glucose index.Georgios Mavraganis, Georgios Georgiopoulos, Stavros Athanasopoulos
|Oct 25, 2025
Cold pressor test and paradoxical blood pressure reduction in light chain amyloidosis.Raphael Patras, Georgios Georgiopoulos, Foteini Theodorakakou
|Feb 24, 2025
Circulating amyloid beta 1-40 peptide as an associate of renal function decline.Georgios Mavraganis, Georgios Georgiopoulos, Georgios Zervas
Pageof 3
Frequent Collaborators
8 joint publications
Georgios Georgiopoulos
8 joint publications
Konstantinos Stellos
4 joint publications
Simon Tual-Chalot
2 joint publications
Efstathios Kastritis
2 joint publications
Luca Liberale
2 joint publications
Simon Kraler
2 joint publications
Dimitris Delialis
2 joint publications
Ignatios Ikonomidis
2 joint publications
Fabrizio Montecucco
2 joint publications
Giovanni G Camici
